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Background
It is becoming more apparent each day that despite a
strong national commitment to excellence in health care,
the resources and personnel are finite. It is, therefore, ap-
propriate that the medical profession examine the impact of
developing technology on the practice and cost of medical
care. Such analysis, carefully conducted, could potentially
impact on the cost of medical care without diminishing the
effectiveness of that care.
To this end, the American College of Cardiology and
the American Heart Association in 1980 established a Joint
Task Force on Assessment of Cardiovascular Procedures
with the following charge:
The Joint Task Force of the American College of Cardiology
and the American Heart Association shall define the role
of specific noninvasive and invasive procedures in the
diagnosis and management of cardiovascular disease.
The Task Force shall address, when appropriate, the
contribution, uniqueness, sensitivity, specificity,
indications and contraindications and cost-effectiveness of
such specific procedures.
The Task Force shall include a Chairman and four members,
two representatives from the American Heart Association
and two representatives from the American College of
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Cardiology. The Task Force may select ad hoc members
as needed upon the approval of the Presidents of both
organizations.
Recommendations of the Task Force are forwarded to the
President of each organization.
The members of the Joint Task Force are: Roman W.
DeSanctis, MD, Harold T. Dodge, MD, T. Joseph Reeves,
MD, Sylvan L. Weinberg, MD and Charles Fisch, MD,
Chairman.
The Subcommitteeon PacemakerImplantation waschaired
by Robert L. Frye, MD and, in addition to the members
of the Joint Task Force, included the following ad hoc
members: John J. Collins, MD, Leonard S. Dreifus, MD,
Leonard S. Gettes, MD, Paul C. Gillette, MD and Victor
Parsonnet, MD.
This document was reviewed by the officers and other
responsible individuals of the two organizations and re-
ceived final approval on May 2, 1984. It is being published
simultaneously in Circulation and Journal of the American
College of Cardiology. The potential impact of this docu-
ment on the practice of cardiology and some of its un-
avoidable shortcomings are clearly set out in the Introduction.
I. Introduction
The joint American College of Cardiology/AmericanHeart
Association Ad Hoc Task Force on Assessment of Cardio-
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vascular Procedures was formed to make recommendations
regarding the appropriate utilization of technology in the
diagnosis and treatment of patients with cardiovascular dis-
ease. One such important techn ique is that of cardiac pacing .
Rapid progre ss in a number of areas has led to extraordinary
and still evolving advances in implantable cardiac pace-
makers and in other devices which electrically stimulate the
heart . For this reason, and also because of allegations of
abuses of this technology, by the medical profession , the
Task Force was assigned the task of defining current indi-
cations for pennanent cardiac pacemakers . These recom-
mendations are the subject of this report. Because of the
multitude, complexity and initial cost of currently available
pacing systems, the Subcommittee has included recom-
mendations regarding selection of devices for specific clin-
ical problems in which pacing is indicated . The Subcom-
mittee recommendations are based on current evidence in
relation to both knowledge of the natural history of disorders
of cardi ac rhythm as well as the characteristics of currently
availabl e pacemakers. Because of continuing research and
development , some of these recommendations may be sub-
ject to modification in even the near future .
These recommendations apply to permanent pacing in
the management of chronic , though sometimes intermittent,
disorders of cardiac rhythm. For the most part , they do not
pertain :0 identifiable factors which cause transient depres-
sion of cardiac impulse formation and conduction , such as
drugs, electrolyte or endocrine imbalances, infection or the
acute phase of myocardial infarction . The decis ion to im-
plant a pacemaker must be reached by scrupulous adherence
to a fundamental principle of clinical medicine which de-
mands a careful, thoughtful analysi s of each individual pa-
tient by the responsible physician. Attention must be given
to the general medical, emotional and mental state of the
patient as well as to the specifics of the cardiac rhythm
disturbance before a proper decision with respect to pacing
can be made.
The Subcommittee has not offered any recommendations
regarding resources required to perform pacemaker inser-
tions , training of individuals for this purpose or the appro-
priate follow-up and monitoring of patients with permanent
pacemakers. These critically important topics have been
addre ssed elsewhere (I). The Subcommittee unanimously
urges careful review of the resource guidelines by all in-
stitutional administrators, physicians and surgeons who are
responsible for pacemaker therapy. The clinical symptom-
atology associated with bradycardia needs definition at the
outset since it recurs throughout the report as a major in-
dication for permanent pacemaker therapy. In this report ,
the term " symptomatic bradycardia" is used to refer to the
following clinical manifestations which are directly attrib-
utable to the slow heart rate: transient dizziness, Iight-head-
edness, near syncope or frank syncope as manifestations of
transient cerebral ischemia, and more generalized symptoms
such as marked exercise intolerance or frank congestive
heart failure .
Indications for permanent pacemakers have been grouped
according to the follo wing classifications:
Class I: Conditions for which there is general agreement
that permanent pacemakers should be implanted .
Class II: Conditions for which permanent pacemakers
are frequently used but there is divergence of
opinion with respect to the necessity of their
insertion.
Class ll/ : Conditions for which there is general agree-
ment that pacemakers are unnecessary.
In those patients being considered for pacemakers, de-
cision making may be influenced by the following additional
factors:
I) overall physical and mental state of the patient, in-
cluding the absence of associated diseases that may
result in a limited prognosis for life;
2) presence of associated underlying cardiac disease that
may be adversely affected by bradycardia;
3) desire of the patient to operate a motor vehicle ;
4) remoteness of medical care , including patients who
travel widely or live alone who therefore might be
unable to seek medical help if serious symptoms arise;
5) necessity for admini stering medication that may de-
press escape heart rates or aggravate atrioventricular
(AV) block ;
6) slowing of the basic escape rates;
7) significant cerebrovascular disease that might result
in a stroke if cerebral perfusion were to suddenly
decrease; and
8) desires of the patient and family.
The format of this report consists of a brief definition
and description of specific clinical situations in which pacing
may be considered, and literature references to document
the basis for the recommendations.
II. Pacing in Acquired Atrioventricular (AV)
Block in Adults
Clinically, atrioventricular (AV) block is classified as
first degree, second degree or third degree (complete) heart
block ; anatomically, it is defined as supra-His , intra-His
and/or infra-His. Second degree heart block may be further
classified as type I (progressive prolongation of PR interval
before a blocked beat) or type II (no progressive prolon-
gation of PR interval before blocked beats). "Advanced
second degree block " refers to the block of two or more
consecutive P waves. Patient s with abnormalities of AV
conduction may be asymptomatic or they may experience
serious symptoms related to profound bradycardia and/or
ventricular arrhythmias . Decisions regarding the need for a
pacemaker are influenced most importantly by the presence
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or absence of symptoms that are directly attributable to
bradycardia. It is clearly documented that patients with com-
plete heart block and syncope have an improved survival
with permanent pacing (2-5). There is no evidence to sug-
gest that survival is prolonged with pacemakers in patients
with isolated first degree AV block. The prognosis in type
I second degree AV block, when due to AV nodal delay,
tends to be benign (6-8). However, in patients with type
II second degree AV block (either intra- or infra-His), symp-
toms are frequent, prognosis is compromised and progres-
sion to complete heart block is common (6,8,9).
Recommendations for insertion of permanent pace-
makers in patients with AV block with acute myocardial
infarction or congenital AV block are discussed in a separate
section. AV block in the presence of supraventricular tach-
yarrhythmia does not constitute an indication for pacemaker
insertion except as specifically defined in the recommen-
dations that follow.
Indications for Permanent Pacing in Acquired AV
Block in Adults
Class I.
A. Complete heart block, permanent or intermittent, at
any anatomic level, associated with anyone of the
following complications:
1. Symptomatic bradycardia (discussed in the Intro-
duction). In patients with these symptoms in the
presence of complete heart block, the symptoms
must be presumed to be due to the heart block
unless proven to be otherwise.
2. Congestive heart failure.
3. Ventricular ectopy and other conditions that re-
quire treatment with drugs which suppress the
automaticity of escape foci.
4. Documented periods of asystole of 3.0 seconds
or longer, or any escape rate of less than 40 beats/
min in symptom-free patients.
5. Confusional states which clear with temporary
pacing.
B. Second degree AV block, permanent or intermittent,
regardless of the type or the site of the block, with
symptomatic bradycardia.
C. Atrial fibrillation, atrial flutter or rare cases of supra-
ventricular tachycardia with complete heart block or
advanced AV block, bradycardia and any of the con-
ditions described under I-A. The bradycardia must
be unrelated to digitalis or drugs known to impair
AV conduction.
Class II.
A. Asymptomatic complete heart block, permanent or
intermittent, at any anatomic site, with ventricular
rates of 40 beats/min or faster.
B. Asymptomatic type II second degree AV block, per-
manent or intermittent.
C. Asymptomatic type I second degree AV block at
intra-His or infra-His levels.
Class III.
A. First degree AV block (see section on bi-trifascicular
block).
B. Asymptomatic type I second degree AV block at the
supra-His (AV nodal) level.
III. Pacing in Atrioventricular (AV) Block
Associated With Myocardial Infarction
Indications for permanent pacing after myocardial in-
farction in patients experiencing AV block are related in
large measure to the presence of intraventricular conduction
defects. The requirement for temporary pacing in acute myo-
cardial infarction does not by itself constitute an indication
for permanent pacing. The long-term prognosis in survivors
of acute myocardial infarction who have had AV block is
related primarily to the extent of myocardial injury and the
character of intraventricular conduction disturbances, rather
than to the AV block per se (10-14). Patients with acute
myocardial infarction who have intraventricular conduction
defects, with the exception of isolated left anterior hemi-
block, have an unfavorable short- and long-term prognosis
and increased incidence of sudden death (10-12). This un-
favorable prognosis is not necessarily due to the develop-
ment of high grade AV block, although the incidence of
such block is higher in postinfarction patients with abnormal
intraventricular conduction (12). Unlike some other indi-
cations for permanent pacing, the criteria in patients with
myocardial infarction and AV block do not necessarily de-
pend on the presence of symptoms.
Indications for Permanent Pacing After
Myocardial Infarction
Class I.
A. Patients with persistent advanced second degree AV
block or complete heart block after acute myocardial
infarction (12,14). Decision for insertion of pace-
maker should be made before discharge in this group
of patients.
Class II.
A. Patients with persistent first degree AV block in the
presence of bundle branch block not documented pre-
viously (13).
B. Patients with transient advanced AV block and as-
sociated bundle branch block.
Class III.
A. Patients in whom AV conduction disturbances are
transient in the absence of intraventricular conduction
defects (12).
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B. Patients with transient AV block in the presence of
isolated left anterior hemiblock (11).
C. Patients with acquired left anterior hemiblock in the
absence of atrioventricular (AV) block.
IV. Pacing in Bifascicular and Trifascicular
Block (Chronic)
Bifascicular and trifascicular block refer to electrocar-
diographic evidence of impaired conduction below the AV
node in two or three of the fascicles of the right and left
bundles. In patients with such electrocardiographic abnor-
malities, there is convincing evidence that advanced heart
block with symptoms due to the block is associated with a
high mortality and a significant incidence of sudden death
(5,15).
Syncope is common in patients with bifascicular block.
It is usually not recurrent, nor is it associated with an in-
creased incidence of sudden death (16-18). It has been
suggested that although pacing relieves the transient neu-
rologic symptoms, it does not reduce mortaility from sudden
death (19). There is convincing evidence, however, that in
the presence of complete heart block, either permanent or
transient, syncope is associated with an increased incidence
of sudden death (5). Thus, being unable to define the cause
of syncope in the presence of bifascicular or trifascicular
block, .r appears reasonable to assume that the syncope may
be due to transient complete heart block and, thus, in the
opinion of some investigators, prophylactic permanent pac-
ing is indicated (20,21).
Although complete heart block is most often preceded
by bifascicular block, the evidence is impressive that the
rate of progression of bifascicular block to complete heart
block i, low. Furthermore, no single clinical or laboratory
variable, including bifascicular block, identifies patients at
high risk of death from a future bradyarrhythmia due to the
bundle branch block (22).
Of the many laboratory variables, the PR and HV inter-
vals have been singled out as possible predictors of complete
heart block and sudden death. Evidence indicates that PR
prolongation is common in patients with bifascicular block.
However, the prolongation is most often at the level of the
AV node. Furthermore, there is no correlation between the
PR and HV intervals, nor is there a correlation between the
length of the PR interval and progression to complete heart
block and incidence of sudden death (23,24,28). Although
most patients with chronic or intermittent complete heart
block demonstrate prolongation of the HV interval during
anterograde conduction, and some investigations (26,27) have
suggested that asymptomatic patients with bifascicular block
and a prolonged HV interval be considered for permanent
pacing, the evidence indicates that while the prevalence of
prolonged HV is high, the incidence of progression to com-
plete heart block is low. HV prolongation accompanies ad-
vanced cardiac disease and is associated with an increased
mortality; death is not sudden and is due to the underlying
heart disease, and not to complete heart block (16,19,
23,28,29). The prolonged HV interval is, thus, not an in-
dependent marker for sudden death (22).
Atrial pacing as a means of identifying patients at in-
creased risk of future complete heart block probably is not
justified. The chance of induction of distal heart block with
pacing is low (16,27,30,31). In fact, pacing often fails to
induce distal His block in patients with documented abnor-
mal conduction of the His-Purkinje system (16,26,27,32,33).
Furthermore, failure to induce distal block cannot be taken
as evidence that the patient will not develop complete heart
block. However, if atrial pacing induces infra-His block,
this may be considered an indication for pacing by some
(34).
Indications for Permanent Pacing in Bifascicular
and Trifascicular Block
Class I.
A. Bifascicular block with intermittent complete heart
block associated with symptomatic bradycardia (as
defined).
B. Bifascicular block with intermittent type II second
degree AV block with symptoms attributable to the
heart block.
Class II.
A. Bifascicular or trifascicular block with intermittent
type II second degree AV block without symptoms.
B. Bifascicular or trifascicular block with syncope that
is not proven to be due to complete heart block, but
other possible causes for syncope are not identifiable.
C. Pacing-induced infra-His block.
Class III.
A. Fascicular blocks without AV block or symptoms.
B. Fascicular blocks with first degree AV block without
symptoms.
V. Pacing in Sinus Node Dysfunction
Sinus node dysfunction (sick sinus syndrome) constitutes
a spectrum of cardiac arrhythmias, including sinus brady-
cardia, sinus arrest, sinoatrial block and paroxysmal supra-
ventricular tachycardia alternating with periods of brady-
cardia or even asystole. Patients with this condition may be
symptomatic from paroxysmal tachycardia, bradycardia or
both. Correlation of symptoms with the specific arrhythmias
is essential. This may be difficult, however, because of the
intermittent nature of the episodes. Sinus bradycardia is
accepted as a physiologic finding in trained athletes, in
whom awake resting heart rates of 40 to 50 beats/min are
not uncommon and minimal heart rates during sleep may
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be as slow as 30 to 43 beats/min with sinus pauses as long
as 1.6 to 2.8 seconds (35-37). This is due to increased vagal
tone. Permanent pacing in patients with sinus node dys-
function may not necessarily result in an improvement in
survival (38,39), but severe symptoms related to bradycar-
dia may be relieved (40,41).
Indications for Permanent Pacing in Sinus
Node Dysfunction
Class I.
A. Sinus node dysfunction with documented sympto-
matic bradycardia. In some patients, this will occur
as a consequence of long-term essential drug therapy
of a type and dose for which there is no acceptable
alternative.
Class II.
A. Sinus node dysfunction, occurring spontaneously or
as a result of necessary drug therapy, with heart rates
below 40 beats/min when a clear association between
significant symptoms consistent with bradycardia and
the actual presence of bradycardia has not been
documented.
Class III.
A. Sinus node dysfunction in asymptomatic patients, in-
cluding those in whom substantial sinus bradycardia
(heart rate <40 beats/min), is a consequence of long-
term drug treatment.
B. Sinus node dysfunction in patients in whom symp-
toms suggestive of bradycardia are clearly docu-
mented not to be associated with a slow heart rate.
VI. Pacing in Hypersensitive Carotid
Sinus Syndrome
The hypersensitive carotid sinus syndrome is defined as
syncope resulting from an extreme reflex response to carotid
sinus stimulation. It is an uncommon cause of syncope.
There are two components to the reflex:
1) Cardioinhibitory, resulting from increased parasympa-
thetic tone and manifested by slowing of the sinus rate
and/or prolongation of the PR interval and advanced AV
block; and
2) Vasodepressor, secondary to a reduction in sympathetic
activity resulting in hypotension.
Before concluding that permanent pacing is clinically
indicated, determination of the relative contribution of the
two components of carotid sinus stimulation to the individ-
ual patient's symptom complex is essential. Hyperactive
response to carotid sinus stimulation is defined as asystole
due either to sinus arrest or AV block of more than 3 seconds
and/or a substantial symptomatic decrease in systolic blood
pressure. However, such heart rate and hemodynamic re-
sponses may occur in normal subjects and patients with
coronary artery disease (42,43), and a conclusion of a cause
and effect relation between the hypersensitive carotid sinus
and the patient's symptoms must be made with great caution.
Minimal pressure on the carotid sinus in the elderly or pa-
tients receiving digitalis may result in marked changes in
heart rate and blood pressure, yet not be of clinical signif-
icance. Permanent pacing for patients with pure excessive
cardioinhibitory response to carotid stimulation is effective
in relieving symptoms (44-46). Since 10 to 20% of patients
with this syndrome may have an important vasodepressor
component, it is necessary to define this before concluding
that all symptoms are related to asystole alone. In patients
with both cardioinhibitory and vasodepressor components,
attention to the latter in patients undergoing permanent pac-
ing is essential for effective therapy.
Indications for Permanent Pacing in Hypertensive
Carotid Sinus Syndrome
Class I.
A. Patients with recurrent syncope associated with clear,
spontaneous events provoked by carotid sinus stim-
ulation, in whom minimal carotid sinus pressure in-
duces asystole of greater than 3 seconds in the ab-
sence of any medication that depresses the sinus node
or AV conduction.
Class II.
A. Patients with recurrent syncope without clear, pro-
vocative events and with a hypersensitive cardioin-
hibitory response.
Class III.
A. Asymptomatic patients with a hyperactive cardioin-
hibitory response to carotid sinus stimulation.
B. Patients with vague symptoms, such as dizziness and/
or light-headedness, and with hyperactive cardioin-
hibitory response to carotid sinus stimulation.
C. Patients with recurrent syncope, light-headedness or
dizziness in whom the vasodepressor response is the
cause for symptoms.
VII. The Use of Pacemakers in Children
Although the indications for pacemakers in children are
similar to those in adults, there are some special consid-
erations. The optimal indication for a pacemaker implan-
tation in a child, as in an adult, is the concurrent observation
of symptoms with bradycardia. For example, a patient with
syncope who is observed electrocardiographically to have
complete AV block or a patient with syncope who is noted
on physical examination to have severe bradycardia such as
a heart rate of 30 beats/min. Concurrence of symptoms and
bradycardia can also be obtained by 24 hour ambulatory
electrocardiography or by transtelephonic electrocardiog-
raphy. Sometimes several 24 hour recordings are necessary.
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Sinus node dysfunction (sick sinus syndrome), although
becoming more frequently recognized in pediatric patients,
is not in and of itself an indication for pacemaker implan-
tation. ln patients with sinus node dysfunction, even greater
emphasis is placed on concurrence of sinus bradycardia or
exit block with symptoms. Sinus node dysfunction is not
likely to be a fatal arrhythmia in infants or children. There-
fore, more time can be spent trying to document the presence
of an arrhythmia during symptoms.
Symptomatic bradycardia (as defined in the Introduction)
with sinus node dysfunction is considered to be an indication
for a pacemaker, assuming that another etiology to account
for such symptoms has been excluded. Such alternate etiol-
ogies to be considered include seizures resulting in hypoxia,
breathholding or infantile apnea.
It is sometimes hard to differentiate whether apnea or
bradycardia occurs first in symptomatic patients. T\1e brady-
cardia-tachycardia syndrome is frequently an indication for
pacemakers in children, particularly if an antiarrhythmic
drug other than digitalis is necessary. It appears that the use
of quinidine or other type I drugs is particularly dangerous
in children with bradycardia-tachycardia syndrome. Pro-
pranolol and amiodarone also severely depress sinus node
function and their use may require the use of a pacemaker
in children with the bradycardia-tachycardia syndrome.
Indications for Permanent Pacing in Children
Class L
A. Second or third degree AV block with symptomatic
bradycardia as defined.
B. Advanced second or third degree AV block with
moderate to marked exercise intolerance.
C. External ophthalmoplegia with bifascicularblock (47).
D. Sinus node dysfunction with symptomatic bradycar-
dia as defined.
E. Bradycardia-tachycardia syndrome in a child with a
need for antiarrhythmic drugs other than digitalis.
F. Congenital AV block with wide QRS escape rhythm
(48).
G. Asymptomatic patients after cardiac surgery with ad-
vanced second or third degree AV block persisting
10 to 14 days postoperatively (49).
Class II.
A. Second or third degree AV block within the bundle
of His in an asymptomatic patient (49).
B. Prolonged subsidiary pacemaker recovery time (50).
C. 1ransient surgical second or third degree AV block,
which reverts to bifasicular block.
D. Asymptomatic children with second or third degree
AV block and a ventricular rate of less than 45 beats/
min when awake (51).
E. Asymptomatic infra-His, second or third degree AV
block (49).
F. An asymptomatic neonate with congenital complete
heart block with bradycardia in relation to age (52).
G. Complex ventricular arrhythmias associated with sec-
ond or third degree AV block or sinus bradycardia
(53).
Class III.
A. Postoperative bifascicular block in the asymptomatic
patient.
B. Postoperative bifascicular block with first degree AV
block in the asymptomatic patient.
C. Transient surgical AV block that returns to normal
conduction in less than 1 week.
D. Asymptomatic type I second degree AV block.
E. Asymptomatic congenital heart block without pro-
found bradycardia in relation to age.
VIII. Pacing for Tachyarrhythmias
The use of implantable cardiac pacemakers to terminate
supraventricular or ventricular tachycardias is just begin-
ning. We will not discuss the use of overdrive pacemakers
for the termination of ventricular tachycardia, since there is
no clinically approved device for this indication and since
the use of this device is still extremely controversial with
risks perhaps outweighing benefits in some patients. The
decision for chronic use of a pacemaker to control tachy-
cardias should be made only after careful observation and
electrophysiologic study by those experienced in this com-
plex field.
Indications for Permanent Pacing
for Tachyarrhythmias
Class I.
A. Patients with symptomatic supraventricular tachy-
cardia which has not responded to a well planned
medical regimen including documentation of ade-
quate serum drug concentrations, or in whom the
medical treatment causes major side effects or in
whom the necessity for taking drugs seriously inhibits
the patient's ability to carry out normal daily func-
tion. Before implantation of an antitachycardia pace-
maker, an electrophysiologic study should be carried
out and the various proposed modes of termination
of tachycardia tested to determine which one is most
appropriate for the particular patient. An external
form of the implantable device should be available
during electrophysiologic study to document the ex-
act settings that will be used and will in fact terminate
the patient's tachycardia. The physician who im-
plants the pacemaker should be prepared to repro-
gram the pacemaker to new settings when the patient
is again active.
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Class II.
None.
Class III.
A. Patients with pre-excitation in whom atrial fibrillation
with rapid ventricular response has occurred spon-
taneously or during electrophysiologic testing.
IX. Clinical Applications of Various
Pacing Modes
This section lists the conditions for which various pacing
modes might be selected. The acceptability of a given mode
of pacing is divided into three classes according to the fol-
lowing definitions:
Class I: Conditions for which there is general agreement
that such a mode of pacing is appropriate.
Class II: Conditions for which a given mode of pacing
may be used, but there is divergence of opinion
with respect to the necessity of that mode of
pacing.
Class Ill: Conditions for which there is general agree-
ment that such a mode of pacing is
inappropriate.
Two varieties of pulse generators are available for per-
manent implantation:
1) single chamber pacemakers (SCP) for use in either
atrium or ventricle; and
2) dual chamber pacemakers (DCP) for use in both cham-
bers (usually programmable to SCP modes as well).
Virtually all modem pacemakers are multiprogramma-
ble, which renders them more or less adaptable to changing
clinical situations. Some pacing modes that were originally
found as specific pacemaker models (such as VOO, VAT
and VVT) are not discussed. *These modes are now optional
settings of multiprogrammable pacemakers. Many new
pacemakers also provide telemetry of stored and variable
data that, on command, can provide information about pace-
maker function and clinical performance. Both program-
mability and telemetry are helpful in optimizing pacemaker
function, avoiding reoperation and extending pulse gener-
ator life. It is essential that the selection process be indi-
vidualized to the needs of the patient, with appropriate con-
sideration given to complication, complexity and cost.
Single Chamber Pacemakers
I. Atrial (AAI): Atrial pacing inhibitedby sensedatrialactivity.
Class I.
A. Symptomatic sinus node dysfunction (sick sinus
syndrome), provided AV conduction is shown to
be adequate by appropriate tests.
*The pacemaker mode is identified according to the Inter-Society Com-
mission for Heart Disease Resources (lCHD) code (I).
Class II.
A. Overdrive of supraventricular or ventricular
arrhythmias.
B. Hemodynamic enhancement through rate adjust-
ment in patients with bradycardia and symptoms
of impaired cardiac output.
Class III.
A. Pre-existing AV conduction delay or block or if PR
interval is inappropriately prolongedby atrialpacing.
B. Inadequate intracavitary atrial complexes.
II. Ventricular (WI): The classic prototypical pacing mode;
ventricular pacing inhibited by sensed spontaneous ventric-
ular activity.
Class I.
A. Any symptomatic bradyarrhythmia, but particu-
larly when there is:
1) no significant atrial hemodynamic contribution
(atrial flutter/fibrillation, giant atria), or
2) no evidence of pacemaker syndrome due to loss
of atrial contribution or negative atrial kick (a
replacement pacemaker)']:
Class II.
A. Symptomatic bradycardia, where pacing simplicity
is a prime concern, in cases of:
1) senility (life-sustaining only),
2) terminal disease,
3) domicile remote from a follow-up center, or
4) intactretrogradeVA (ventriculoatrial) conduction.
Class III.
A. Known pacemaker syndrome (a replacement pace-
maker) or symptoms produced by temporary ven-
tricular pacing at the time of initial pacemaker
implantation.
B. The need for maximal atrial contribution, because
of:
1. congestive heart failure, or
2. special need for rate responsiveness.
Dual Chamber Pacemakers
I. VDD: Ventricular pacing in synchrony with sensed atrial
activity, inhibited by sensed ventricular activity. (Although
these units are rate-responsive, at a slow atrial rate below
the set rate of the pacemaker only the ventricle is paced, in
which case the pacemaker functions as a VVI unit.)
tThe pacemaker syndrome was first defined as the light-headedness or
syncope related to long cycles of AV asynchrony that occurred at times
during VVI or VOO pacing. The definition is now expanded to include:
I) episodic weakness or syncope associated with alternating AV synchrony
and asynchrony; 2) inadequate cardiac output associated with continued
absence of AV synchrony or with fixed asynchrony (persistent VA con-
duction); and 3) patient awareness of beat to beat variations in cardiac
contractile sequence, often as a result of: a) cannon A waves; b) V waves
transmitted to the atria or pulmonary veins; and c) bundle branch block
patterns of ventricular contraction with a paced beat.
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Class I.
A Requirements for ventricular pacing when adequate
atrial rates and adequate intracavitary atrial com-
plexes are present. This includes the presence of
complete AV block in patients:
I) requiring atrial contribution for hemodynamic
benefit, or
2) withprevious or anticipated pacemaker syndrome,
Class II.
A, Normal sinus rhythm and normal AV conduction
in patients needing ventricular pacing intermittently,
Class III.
A. Frequent or persistent supraventricular tachyar-
rhythmias, including atrial fibrillation or flutter.
B, Inadequate intracavitary atrial complexes,
II, DVI ' Pacing of both chambers at a preselected minimal
rate, inhibited by ventricular but not atrial activity,
Class I.
A The need for synchronous atrial-ventricular con-
traction in patients with symptomatic bradycardia
and a slow atrial rate,
B. Patients with previously documented pacemaker
syndrome.
Class II.
A, Overdrive of certain arrhythmias.
B. Frequent supraventricular arrhythmias in which
combined pacing and drugs have been shown to be
therapeutically effective.
C. Bradycardia-tachycardia syndrome. provided ad-
justment of atrial rate and AV interval terminates
or prevents the emergence of supraventricular ar-
rhythmias with or without concomitant drug
administration.
Class III.
A. Frequent or persistent supraventricular tachyar-
rhythmias, including atrial fibrillation or flutter.
III. DDj) : Pacing of both chambers, sensing of both cham-
bers, inhibitionof atrial or ventricular output by sensed atrial
or ventricular activity; triggering of ventricular output by
sensed atrial activity.
Class I.
A. Requirement for AV synchrony over a wide range
of rates such as:
I . the active or young patient with atrial rates re-
sponsive to clinical need,
2. signifi cant hemodynamic need, and
3. pacemaker syndrome during previous pace-
maker experience, or a reduction in systolic blood
pressure of more than 20 mm Hg during ven-
tricular pacing at the time of pacemaker im-
plantation (with or without evidence of VA
conduction).
Class II.
A. Complete heart block or sick sinus syndrome and
stable atrial rates,
B, Any patient in whom simultaneous control of atrial
and ventricular rates inhibits tachyarrhythmias or
in whom the pacemaker can be adjusted to a mode
designed to interrupt the arrhythmia,
Class III.
A, Frequent or persistent supraventricular tachyar-
rhythmias, including atrial fibrillation or flutter.
B. Inadequate intracavitary atrial complexes.
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